A search in PubMed revealed that 72 radionuclides have been considered for molecular or
functional targeted radionuclide therapy. As radionuclide therapies increase in number and …

This chapter will focus primarily on the selection criteria, production, and the nuclear,
physical, and chemical properties of therapeutic radionuclides, including those that are …

We read with interest the letter by Giammarile et al.[1] addressing our editorial in which we
proposed that the European Medicines Agency should allow the option of a dosimetrybased …

Radiation oncologists and nuclear medicine physicians have seen a resurgence in the
clinical use of radiopharmaceuticals for the curative or palliative treatment of cancer. To …

Radionuclide therapy (RNT) based on the concept of delivering cytotoxic levels of radiation
to disease sites is one of the rapidly growing fields of nuclear medicine. Unlike conventional …

Radiopharmaceutical therapy or targeted radionuclide therapy (TRT) is a well-established
class of cancer therapeutics that includes a growing number of FDA-approved drugs and a …

As more radionuclide therapies move from laboratory feasibility studies into clinical reality, it
becomes increasingly important for the labeling chemistry to produce consistently a stable …

Nuclear Medicine provides efficient tools for cancer therapy using compounds labelled with
radionuclides that emit beta-particles, alpha-particles or Auger electrons. With their short …

Advances in the field of molecular biology have had an impact on biomedical applications,
which provide greater hope for both imaging and therapeutics. Work has been intensified on …

Molecular imaging and radiotherapy using radionuclides is a rapidly expanding field of
medicine and medical research. This article highlights the development of the role of …